<DOC>
	<DOCNO>NCT00535236</DOCNO>
	<brief_summary>The propose indication investigational heat-treated varicella-zoster virus ( VZV ) vaccine prevention herpes zoster ( HZ ) HZ-related complication immunocompromised individual .</brief_summary>
	<brief_title>A Study Investigational V212/Heat-Treated VZV Vaccine Immunocompromised Adults ( V212-002 ) ( COMPLETED )</brief_title>
	<detailed_description />
	<mesh_term>Herpes Zoster</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Men woman &gt; = 18 year age schedule receive autologous allogeneic hematopoietic cell transplant within 60 day enrollment HIVinfected patient baseline CD4 cell count &lt; = 200 cells/mm^3 Patients hematologic malignancy ; patient receive chemotherapy breast , colorectal , lung , ovarian malignancy History allergy vaccine component Prior history HZ Prior history receipt varicella zoster vaccine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Prevention herpes zoster HZ-related complication</keyword>
</DOC>